Collagen and Gelatin Market for Regenerative Medicine – Anticipated To Witness High Growth In The Near Future

PUNE, India, 2020-May-21 — /EPR Network/ —

The key factors propelling the growth of the Global Collagen and Gelatin Market for Regenerative Medicine include rising prevalence of chronic diseases, rapid growth in aging population, and growing government & private funding to support the development of regenerative medicine.

The Global Collagen Market for regenerative medicine is projected to grow $679.9 Million, at a CAGR of 10.1% during the forecast period.

The Global Gelatin Market for regenerative medicine is projected to reach $94.9 Million, at a CAGR of 7.8% during the forecast period.

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global collagen and gelatin industry for regenerative medicine and estimate the size of other dependent submarkets. Various secondary sources such as associations (including Food and Drug Administration, World Health Organization, Centers for Disease Control and Prevention, Organisation for Economic Co-operation and Development, Institute of Biomaterial Science, Medical Design Technology Magazine, Centre for Biomedical and Biomaterials Research, Centre for Advanced Materials and Biomaterials Research, Institute of Biomaterials and Bioengineering, Biomaterials Research Center), directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122

Market Segmentation in Depth:

On the basis of source, the global collagen market for regenerative medicine has been segmented into bovine collagen, porcine collagen, marine collagen, and other sources. The bovine collagen segment is expected to command the largest share of the global collagen market for regenerative medicine. The large share of this segment is attributed to the lower cost and extensive availability of bovine collagen.

on the basis of source, the global gelatin market for regenerative medicine has been segmented into bovine gelatin, porcine gelatin, and gelatin from other sources. The bovine gelatin segment is expected to command the largest share of the global gelatin market for regenerative medicine. Owing to its extensive availability, this segment is also projected to register the highest CAGR during the forecast period.

On the basis of application, the global collagen market for regenerative medicine has been categorized into orthopedic, wound care, cardiovascular, and other applications. The orthopedic applications segment is expected to command the largest share of the global collagen market for regenerative medicine. The large share of this segment can primarily be attributed to the high prevalence of osteoporosis. The wound care segment is projected to register the highest CAGR during the forecast owing to factors such as rising prevalence of chronic wounds.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95663122

Geographically, the global collagen & gelatin market for regenerative medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America dominated the market, and this is primarily attributed to high incidence of periodontitis, increasing prevalence of heart diseases & diabetes in the U.S., and growing number of research studies in Canada. The Asia-Pacific region is expected to witness the highest CAGR during the forecast period, owing to the large number of CVD patients and diabetics with DFU (diabetic foot ulcers) in the region, increasing number of research studies, and increasing focus of industry players on emerging APAC countries.

The major players operating in the global collagen market for regenerative medicine include Integra LifeSciences Holding Corporation (U.S.), Collagen Matrix, Inc. (U.S.), Collagen Solutions plc (U.K.), Royal DSM (Netherlands), Vornia Biomaterials, Ltd. (Ireland), SYMATESE (France), and NuCollagen, LLC. (U.S.). Similarly, the major players operating in the global gelatin market for regenerative medicine include GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium).